You are here: Home » Companies » News
Business Standard

Manappuram Finance's Rs 1.5-bn equity infusion in subsidiary gets go-ahead

Asirvad Micro Finance has paid up capital of Rs 425 million with turnover of Rs 4.37 bn (as at March 2018)

Press Trust of India  |  New Delhi 

Manappuram Finance

on Wednesday said its board has approved equity infusion of up to Rs 1.50 bn in its arm Asirvad

"The Board of Directors at their meeting dated November 6, 2018 approved equity infusion up to Rs 1.50 bn in its subsidiary Asirvad Ltd(Asirvad)," said in a BSE filing.

Asirvad has paid up capital of Rs 425 million with turnover of Rs 4.37 bn (as at March 2018), the filing added.

The capital infusion is a related party transaction and will be made at arms length, it said.

Asirvad operates in the The capital infusion will facilitate in business growth of the subsidiary. Being the largest business, after gold loans, micro finance is strategically important to the company, added.

The company also said no governmental/regulatory approvals are required for the proposed capital infusion and the time period for the transaction will be five months.

Asirvad is an NBFC (company) incorporated on August 29 2007 with registered office in Chennai.

It was set up by its present Managing Director S V Raja Vaidyanathan. In February 2015, Manappuram Finance acquired 85 per cent stake in Asirvad and subsequently increased it to 92.30 per cent.

It had Assets under Management (AUM) of Rs 27.28 bn as on September 30, 2018.

First Published: Wed, November 07 2018. 19:45 IST